In a video interview with Healio, Benjamin N. Ungar, MD, discussed the risk factors of atopic dermatitis and the comorbidities associated with the condition.
Q4 2024 Earnings Call Transcript March 27, 2025 STRATA Skin Sciences, Inc. misses on earnings expectations. Reported EPS is $ ...
Robert Sidbury MD, MPH explored the “long list” of treatment options in atopic dermatitis and how the treatment landscape has changed as a result in a video interview with Healio.“So long list – I ...
Researchers examined the risk for serious infection among patients with atopic dermatitis treated with Janus kinase inhibitors vs Th2 cytokine inhibitors.
Soquelitinib Atopic Dermatitis Phase 1 Clinical Trial Data From Cohorts 1-3 anticipated to be Presented in MayInitial Results From First Two ...
Stock analysts at HC Wainwright lifted their FY2025 earnings per share estimates for shares of Corvus Pharmaceuticals in a ...
Corvus Pharmaceuticals has faced volatility due to mixed clinical data and given the current valuation and market ...
Health on MSN1d
What's the Difference Between Asthma and Chronic Obstructive Pulmonary Disease (COPD)?Medically reviewed by Sanja Jelic, MD Asthma and chronic obstructive pulmonary disease (COPD) are chronic respiratory (lung) ...
Shares of Incyte Co. (NASDAQ:INCY – Get Free Report) have been given a consensus recommendation of “Hold” by the nineteen ...
RKF Jr. said "a lot of studies" show that getting measles "boosts your immune system later in life" but there’s no conclusive ...
Many patients who achieved clear skin with tapinarof treatment maintained low disease activity after a treatment-free interval.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback